Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Tables)

v3.21.2
Stockholders’ Equity (Tables)
 3 Months Ended
Oct. 31, 2021
Stockholders' Equity Note [Abstract]  
Schedule of amounts of share-based compensation expense
    Three months ended
October 31,		  
    2021     2020  
Stock options and restricted stock   $ 150       167  
Performance stock units     66      
—
  
    $ 216       167  

 
Schedule of share-based payment arrangement
    Three months ended
October 31,		  
    2021     2020  
Selling, general and administrative   $ 212       154  
Cost of revenues     4       13  
    $ 216       167  

 
Schedule of stock option activity
     Options         Weighted
Average
Exercise
Price		     Weighted
Average
Remaining
Contractual
Term		     Aggregate
Intrinsic
Value (000s)		  
Outstanding at July 31, 2021       2,504,563     $ 3.74                  
Awarded     2,000     $ 3.64                  
Exercised    
—
                     $    
Cancelled or expired     (3,000 )   $ 2.14                  
Outstanding at end of period     2,503,563     $ 3.74       2.15 years       $ 1,550  
Exercisable at end of period     1,610,326     $         1.2 years       $    

 
Schedule of nonvested performance-based units activity
Grant Date   Total Grant     Forfeitures     Outstanding    

Fair Market Value

At Grant Date (000s)

  
10/15/2019     80,500       (14,500 )     66,000     $ 222  
10/19/2020     98,600      
—
       98,600     $ 207